The Latest Breaking News from BARDA

Federal Money Moves Toward a Last Resort Antibiotic for Children as an FDA Decision Approaches in February

BARDA exercised a $36.9 million cefiderocol option under a contract that also funds a pediatric expansion now under FDA review.

Medical Daily · Sep 4

Washington Places Its First Order Under a Federal Contract to Stockpile an Antibiotic for Resistant Infections

BARDA exercised a $36.9 million option to buy cefiderocol for national preparedness. Here is what the antibiotic treats and who it helps.

Medical Daily · Aug 28

Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company’s messenger RNA programs, vaccine approvals and upcoming clinical milestones during a presentation at the Jefferies Global Healthcare Conference in New York. Payne described Arcturus as a “next generation messen

MarketBeat · Jun 5

Cassidy says canceled vaccine research needed to fight pandemics - Roll Call

The chairman of the Senate Health, Education, Labor and Pensions Committee denounced a decision by the federal government to phase out mRNA vaccine development, warning that could hurt pandemic preparedness.

Roll Call · Aug 7, 2025

Former Trump official calls Kennedy’s latest move a ‘huge strategic misstep’ that ‘deeply compromises national security’

What Kennedy just canceled will terrify you.

We Got This Covered · Aug 6, 2025

HHS phases out mRNA vaccine trials for COVID-19, bird flu - Roll Call

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine priorities.

Roll Call · Aug 6, 2025

US Axes MRNA Vaccine Contracts, Casting Safety Doubts

President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives.

International Business Times · Aug 6, 2025

Despite RFK Jr’s hesitancy the HHS is quietly looking at developing two new vaccines

The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the same family as the Ebola virus

The Independent UK · Jul 8, 2025

Trump betting on old vaccine tech

It's in sharp contrast to Operation Warp Speed, which led to the creation of the COVID vaccines

Salon · May 6, 2025

As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable.

Fortune · Jan 23, 2025